1. Adverse reactions with levofloxacin in Belgium

   News item 17 January 2013 Pages: 2 - 2

2. Capecitabine labelling change warns of warfarin interaction

   Media release 17 January 2013 Pages: 2 - 2

3. Thrombotic risks of OC use highlighted in Norway

   News item 17 January 2013 Pages: 2 - 2

4. Isoniazid: complex regional pain syndrome

   Correspondence 17 January 2013 Pages: 3 - 3

5. Sodium phosphate: electrolyte disorders with > 45ml

   Media release 17 January 2013 Pages: 3 - 3

6. Type of administration affects risk of death with irinotecan regimen?

   Correspondence 17 January 2013 Pages: 3 - 3

7. Aprotinin: anaphylaxis following re-exposure

   Incidence study 17 January 2013 Pages: 4 - 4

8. Cisapride reduces maximum cystometric capacity

   Volunteers 17 January 2013 Pages: 4 - 4

9. Most postdischarge ADRs in France are `preventable'

   Clinical study 17 January 2013 Pages: 4 - 4

10. Nitrous oxide 50% well tolerated in paediatric patients

    Clinical study 17 January 2013 Pages: 4 - 4

11. Mycophenolate mofetil implicated in polyoma viral infection

    Clinical study 17 January 2013 Pages: 5 - 5

12. Pranlukast for aspirin-induced bronchoconstriction

    Clinical study 17 January 2013 Pages: 5 - 5

13. Proximity of injection site determines brainstem sufentanil concentrations

    Animal 17 January 2013 Pages: 5 - 5

14. SSRIs/TCAs: cardiovascular effects

    Clinical study 17 January 2013 Pages: 5 - 5

15. Bezafibrate

    Case report 17 January 2013 Pages: 6 - 6

16. Ceftizoxime

    Case report 17 January 2013 Pages: 6 - 6

17. Sevoflurane: epileptiform EEG activity

    Incidence study 17 January 2013 Pages: 6 - 6

18. Sirolimus: severe eyelid oedema

    Incidence study 17 January 2013 Pages: 6 - 6

19. Celecoxib

    Case report 17 January 2013 Pages: 6 - 7

20. Chlorpromazine

    Case report 17 January 2013 Pages: 7 - 7

21. Dalteparin sodium/tinzaparin sodium

    Case report 17 January 2013 Pages: 7 - 7

22. Didanosine/stavudine

    Case report 17 January 2013 Pages: 7 - 7

23. Estrogens/progestogens

    Case report 17 January 2013 Pages: 7 - 7

24. Etanercept

    Case report 17 January 2013 Pages: 7 - 8

25. Ethosuximide

    Case report 17 January 2013 Pages: 8 - 8

26. Fenofibrate/pravastatin/simvastatin

    Case reports 17 January 2013 Pages: 8 - 8

27. Flecainide

    Case report 17 January 2013 Pages: 8 - 8

28. Gabapentin withdrawal

    Case reports 17 January 2013 Pages: 8 - 9

29. Gammaglobulin

    Case reports 17 January 2013 Pages: 9 - 9

30. Herbal medicines

    Case report 17 January 2013 Pages: 9 - 9

31. Interferon-α

    Case report 17 January 2013 Pages: 9 - 9

32. Interferon-α

    Case report 17 January 2013 Pages: 9 - 9

33. Interferon-α-2b

    Case report 17 January 2013 Pages: 9 - 10

34. Methylprednisolone/prednisolone

    Case reports 17 January 2013 Pages: 10 - 10

35. Methylprednisolone/prednisone

    Case report 17 January 2013 Pages: 10 - 10

36. Nafarelin

    Case report 17 January 2013 Pages: 10 - 10

37. Paclitaxel

    Case report 17 January 2013 Pages: 11 - 11

38. Paroxetine/sertraline

    Case reports 17 January 2013 Pages: 11 - 11

39. Phenoxyethanol

    Case report 17 January 2013 Pages: 11 - 11

40. Phenytoin

    Case report 17 January 2013 Pages: 11 - 11

41. Sertraline

    Case report 17 January 2013 Pages: 11 - 11

42. Valproate semisodium

    Case report 17 January 2013 Pages: 12 - 12